The U.S. Food and Drug Administration (FDA) has updated information on its website for blood establishments about donating blood during the COVID-19 pandemic.
The website provides information on when people who have received a SARS-CoV-2 vaccine may safely donate blood.
The information is as follows:
· people who received a nonreplicating, inactivated, or mRNA-based COVID-19 vaccine can donate blood without a waiting period
· people who received a live-attenuated viral COVID-19 vaccine, refrain from donating blood for a short waiting period (e.g., 14 days) after receipt of the vaccine,
· people who are uncertain about which COVID-19 vaccine was administered, refrain from donating for a short waiting period (e.g., 14 days) if it is possible that the individual received a live-attenuated viral vaccine.
